Learn more about the summit, and register here: #GLP1Summit #GLP1 #PrescriptionTrends #PrescribingTrends #PrescriptionData #Tirzepatide #Semaglutide #EHRData #ClinicalExpertLedAI #MedicalAI #HealthAI #HealthcareAI #AI #Innovation #RealWorldData #RWD Truvetas Post One week from today, our Director of Life Sciences Harshita Ravishankar, MD MPA, will be presenting at the inaugural GLP-1-Based Therapeutics Summit in Philadelphia on real-world GLP-1 prescribing trends gleaned from Truveta Data
How Should Liposomal Glutathione Be Taken
Generally, research suggests that injectable semaglutide achieves significantly greater HbA1c reductions compared to oral forms in those with type 2 diabetes
We have to be very careful, as an industry, how we position these types of ingredients and how we manage consumer expectations, she says
The most common side effects for both drugs are gastrointestinal
The science couldnt be clearer: GLP-1s arent short-term fixes
